tiprankstipranks
Advertisement
Advertisement

AXSM Stock Latest News

Shopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
The FlyShopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
1d ago
GS
RL
Axsome Therapeutics initiated with an Outperform at BMO Capital
PremiumThe Fly
Axsome Therapeutics initiated with an Outperform at BMO Capital
2d ago
AXSM
Axsome Therapeutics initiated with an Outperform at BMO Capital
PremiumThe Fly
Axsome Therapeutics initiated with an Outperform at BMO Capital
2d ago
AXSM
Axsome Therapeutics announces FDA acceptance of AXS-12 NDA
PremiumThe Fly
Axsome Therapeutics announces FDA acceptance of AXS-12 NDA
7d ago
AXSM
Axsome Therapeutics: SUNOSI IP De-Risked, ADHD Phase 3 Expansion Supports Reaffirmed $290 12-Month Price Target and Buy Rating
PremiumRatings
Axsome Therapeutics: SUNOSI IP De-Risked, ADHD Phase 3 Expansion Supports Reaffirmed $290 12-Month Price Target and Buy Rating
14d ago
AXSM
Axsome Therapeutics price target raised to $304 from $302 at RBC Capital
PremiumThe FlyAxsome Therapeutics price target raised to $304 from $302 at RBC Capital
15d ago
AXSM
Blair adds American Express, Oracle to Conviction List in monthly update
Premium
The Fly
Blair adds American Express, Oracle to Conviction List in monthly update
21d ago
P
CW
Axsome Therapeutics doses first patient in FOCUS-3 trial
Premium
The Fly
Axsome Therapeutics doses first patient in FOCUS-3 trial
26d ago
AXSM
Axsome Therapeutics price target raised to $300 from $275 at TD Cowen
PremiumThe Fly
Axsome Therapeutics price target raised to $300 from $275 at TD Cowen
1M ago
AXSM
Axsome Shareholders Back Directors, Auditor and Executive Pay
PremiumCompany Announcements
Axsome Shareholders Back Directors, Auditor and Executive Pay
1M ago
8K
AXSM
Axsome adopts new executive severance and control plan
PremiumCompany Announcements
Axsome adopts new executive severance and control plan
1M ago
8K
AXSM
Axsome Therapeutics: Buy Rating Reiterated, $290 Price Target Unchanged on Extended SUNOSI Exclusivity and Late-Stage Pipeline Progress
PremiumRatings
Axsome Therapeutics: Buy Rating Reiterated, $290 Price Target Unchanged on Extended SUNOSI Exclusivity and Late-Stage Pipeline Progress
2M ago
AXSM
Analyst Reaffirms Buy on Axsome as Auvelity Peak Sales Outlook Surges Above $8B and Cash Runway Extends to Breakeven
PremiumRatingsAnalyst Reaffirms Buy on Axsome as Auvelity Peak Sales Outlook Surges Above $8B and Cash Runway Extends to Breakeven
2M ago
AXSM
Axsome secures long-term U.S. exclusivity for SUNOSI
Premium
Company Announcements
Axsome secures long-term U.S. exclusivity for SUNOSI
2M ago
8K
AXSM
Axsome Therapeutics announces settlement resolving Sunosi patent litigation
Premium
The Fly
Axsome Therapeutics announces settlement resolving Sunosi patent litigation
2M ago
AXSM
Truist’s Suvannavejh Lifts Auvelity Outlook and Sets $310 Price Target on Axsome Therapeutics Buy Rating
PremiumRatings
Truist’s Suvannavejh Lifts Auvelity Outlook and Sets $310 Price Target on Axsome Therapeutics Buy Rating
2M ago
AXSM
Axsome Therapeutics price target lowered to $280 from $281 at Deutsche Bank
PremiumThe Fly
Axsome Therapeutics price target lowered to $280 from $281 at Deutsche Bank
3M ago
AXSM
Axsome Therapeutics price target raised to $267 from $255 at Needham
PremiumThe Fly
Axsome Therapeutics price target raised to $267 from $255 at Needham
3M ago
AXSM
Axsome Therapeutics price target raised to $242 from $217 at Morgan Stanley
PremiumThe Fly
Axsome Therapeutics price target raised to $242 from $217 at Morgan Stanley
3M ago
AXSM
Axsome Therapeutics price target raised to $302 from $242 at RBC Capital
PremiumThe FlyAxsome Therapeutics price target raised to $302 from $242 at RBC Capital
3M ago
AXSM
Axsome Therapeutics price target raised to $310 from $228 at Mizuho
Premium
The Fly
Axsome Therapeutics price target raised to $310 from $228 at Mizuho
3M ago
AXSM
Axsome Therapeutics price target raised to $246 from $241 at Baird
Premium
The Fly
Axsome Therapeutics price target raised to $246 from $241 at Baird
3M ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >